CAS
CORZ icon

CTC Alternative Strategies’s Core Scientific CORZ Stock Holding History

CTC Alternative Strategies’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,900
Closed -$113K – 202
2024
Q1 		$113K Buy
+31,900
New +$111K 0.07% 72

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

CTC Alternative Strategies's CORZ Position: Q2 2024 in Review

CTC Alternative Strategies sold out of Core Scientific (CORZ) in Q2 2024, closing a stake of 31,900 shares — an estimated $113K sold.

CTC Alternative Strategies first reported a position in CORZ in Q1 2024 and held it in 1 quarter. The position peaked at $113K in Q1 2024. 189 funds tracked by Wall St. Rank hold CORZ as of Q2 2024.

  • CTC Alternative Strategies reported no remaining Core Scientific position as of Q2 2024 after selling out during the quarter.
  • CTC Alternative Strategies sold 31,900 Core Scientific shares in Q2 2024, an estimated $113K.
  • CTC Alternative Strategies first reported a position in Core Scientific in Q1 2024 and held it in 1 quarter.
  • CTC Alternative Strategies's Core Scientific position peaked at $113K in Q1 2024.
  • 189 funds tracked by Wall St. Rank held Core Scientific as of Q2 2024.

Based on CTC Alternative Strategies's 13F filing for Q2 2024, filed 2 Aug 2024.